oneplacenewsSource: ScienceDaily Health
Summary
Researchers have discovered that UNI418 can inhibit the DNA repair mechanism in cancer cells, enhancing the effectiveness of treatments. This strategy, especially when paired with a PARP inhibitor, shows promise in reversing drug resistance in challenging cancer cases.
Why It Matters
This breakthrough is crucial in the ongoing battle against chemotherapy resistance, which often limits treatment options and outcomes for patients. By targeting the repair processes of cancer cells, this research opens new avenues for more effective therapies, potentially improving survival rates and patient quality of life.
